Abstract
Pulmonary arterial hypertension (PAH) is a frequently diagnosed complication in patients with congenital heart disease (CHD). The majority of the cases involve patients with nonrestrictive congenital cardiac shunts with unprotected pulmonary blood flow. Exposure of the pulmonary vasculature to increased blood flow and pressure results in vascular remodelling and eventually established pulmonary vascular disease. Despite advances in the understanding of the pulmonary vascular disease, advances in surgical repair of congenital heart disease and the development of drug therapies, PAH still occurs after successful corrective surgery in patients with CHD and results in significant morbidity and mortality. In this chapter, we discuss the pathogenesis, presentation, natural history and management of PAH in patients with previous surgical or percutaneous repair of CHD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ASD:
-
Atrial septal defect
- AVSD:
-
Atrioventricular septal defect
- BMPR-2:
-
Bone morphogenetic protein receptor type 2
- CHD:
-
Congenital heart disease
- CTD:
-
Connective tissue disease
- ERA:
-
Endothelin receptor antagonist
- ES:
-
Eisenmenger syndrome
- FC:
-
Functional class
- iPAH:
-
Idiopathic pulmonary arterial hypertension
- LHD:
-
Left heart disease
- mPAP:
-
Mean pulmonary artery pressure
- NT-proBNP:
-
N-terminal prohormone of brain natriuretic peptide
- PAH:
-
Pulmonary arterial hypertension
- PAH–CHD:
-
Pulmonary arterial hypertension in congenital heart disease
- PDE5:
-
Phosphodiesterase 5
- PGs:
-
Prostaglandins
- PVR:
-
Pulmonary vascular resistance
- PVRI:
-
Pulmonary vascular resistance indexed
- RCT:
-
Randomized control trials
- RV:
-
Right ventricle
- TGA:
-
Transposition of great arteries
- VSD:
-
Ventricular septal defect
- WHO:
-
World Health Organization
- 6MWT:
-
6-min walk test
References
Wood P (1958) The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J 2(5098):701–709
Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ (2011) Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol 58(5):538–546
Diller GP, Gatzoulis MA (2007) Pulmonary vascular disease in adults with congenital heart disease. Circulation 115(8):1039–1050
Sanatani S, Wilson G, Smith CR, Hamilton RM, Williams WG, Adatia I (2006) Sudden unexpected death in children with heart disease. Congenit Heart Dis 1(3):89–97
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D34–D41
Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L (2007) Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115(2):163–172
Adatia I, Kothari SS, Feinstein JA (2010) Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):52S–61S
Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW et al (2007) Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 120(2):198–204
Mulder BJ (2010) Changing demographics of pulmonary arterial hypertension in congenital heart disease. Eur Respir Rev 19(118):308–313
D’Alto M, Mahadevan VS (2012) Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev 21(126):328–337
Gatzoulis MA, Alonso-Gonzalez R, Beghetti M (2009) Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. Eur Respir Rev 18(113):154–161
Engelfriet PM, Duffels MG, Moller T, Boersma E, Tijssen JG, Thaulow E et al (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: the euro heart survey on adult congenital heart disease. Heart 93(6):682–687
Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, Ruiz JM, Gonzalez IO, Cubero JS et al (2015) Pulmonary hypertension and congenital heart disease: an insight from the REHAP National Registry. Int J Cardiol 184:717–723
van Loon RL, Roofthooft MT, Hillege HL, ten Harkel AD, van Osch-Gevers M, Delhaas T et al (2011) Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 124(16):1755–1764
Berger RM, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing ZC et al (2012) Clinical features of paediatric pulmonary hypertension: a registry study. Lancet 379(9815):537–546
Haworth SG, Hislop AA (2009) Treatment and survival in children with pulmonary arterial hypertension: the UK pulmonary hypertension Service for Children 2001-2006. Heart 95(4):312–317
Rabinovitch M (1999) Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant 18(11):1041–1053
Haworth SG (2002) Pulmonary hypertension in the young. Heart 88(6):658–664
Haworth SG (1984) Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. Br Heart J 52(5):557–571
Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galie N (2013) Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 35(11):716–724
Roberts KE, McElroy JJ, Wong WP, Yen E, Widlitz A, Barst RJ et al (2004) BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 24(3):371–374
Vida VL, Padalino MA, Boccuzzo G, Tarja E, Berggren H, Carrel T et al (2010) Scimitar syndrome: a European Congenital Heart Surgeons Association (ECHSA) multicentric study. Circulation. 122(12):1159–1166
Tinker A, Uren N, Schofield J (1989) Severe pulmonary hypertension in Ullrich-Noonan syndrome. Br Heart J 62(1):74–77
Slavotinek A (2003) Chromosome 1p36 deletions. Orphanet encyclopedia [Internet]
Soubrier F, Chung WK, Machado R, Grunig E, Aldred M, Geraci M et al (2013) Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 62(25 Suppl):D13–D21
Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD et al (2012) Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 125(1):113–122
Rosenkranz S, Ghofrani HA, Beghetti M, Ivy D, Frey R, Fritsch A et al (2015) Riociguat for pulmonary arterial hypertension associated with congenital heart disease. Heart 101(22):1792–1799
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galie N, Ghofrani HA et al (2013) Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 369(9):809–818
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galie N et al (2015) Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med 373(26):2522–2533
Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119
Dimopoulos K, Giannakoulas G, Wort SJ, Gatzoulis MA (2008) Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications. Curr Opin Cardiol 23(6):545–554
Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G et al (1998) Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19(12):1845–1855
Baruteau AE, Belli E, Boudjemline Y, Laux D, Levy M, Simonneau G et al (2015) Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. Eur J Cardiothorac Surg 47(3):e105–e110
Perloff JK, Warnes CA (2001) Challenges posed by adults with repaired congenital heart disease. Circulation 103(21):2637–2643
Rajdev A, Garan H, Biviano A (2012) Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis 55(2):180–186
Handoko ML, Lamberts RR, Redout EM, de Man FS, Boer C, Simonides WS et al (2009) Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am J Physiol Heart Circ Physiol 297(5):H1752–H1759
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Moledina, S., Theocharis, P. (2017). Pulmonary Arterial Hypertension in Patients with Previous Reparative Surgery. In: Dimopoulos, K., Diller, GP. (eds) Pulmonary Hypertension in Adult Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-46028-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-46028-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46026-0
Online ISBN: 978-3-319-46028-4
eBook Packages: MedicineMedicine (R0)